Genentech culture not as it used to be - Recensione dipendente - Dipendente anonimo presso Genentech

2,0
30 gen 2017
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

- Good company to work for up to late 2000's

Svantaggi

- Roche takeover in 2009 - Mismanagement at low to mid level since then - Nepotism is rampant - Talk of work/life balance is just talk - Salary not commensurate with added responsibilities - Raises/promotions are few and far between

Esplora altre recensioni su Genentech

5,0
6 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great salary and team! The interview process was smooth and effective.

Svantaggi

To be determined, but so far many alignment meetings. Some folks have frustuations around the re-org and strategy changes.

3,0
7 mag 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Genentech's origin story and mission are genuinely inspiring — few companies can point to such a meaningful historical arc in medicine. Patient engagement is taken seriously and feels authentic, not performative. The campus is beautiful and the culture has real warmth.

Svantaggi

DDA is operating with significant gaps. First, the foundational data infrastructure is not mature enough to support the ambitions being set for the team. Second, the measurement culture has gotten ahead of the methodology, and no one in a position of authority seems to be asking hard questions about whether the numbers actually mean what they're being presented as meaning. Third, some management feel disconnected from the work itself, lacking the knowledge, hands-on experience, or relevant credentials. Individually any one of these would be manageable. Together these create an environment where it's hard to do rigorous work, rather work is performative, and be recognized for it.

2
Vedi recensioni per: Utile|Valutazione|Data|Tutto